Clinical Trials Browser

pexidartinib × Lymphoid × Clear all

NCT01217229 2020-06-30

Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma

Phase 2 Completed

20 enrolled 7 charts

Hodgkin Disease